Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(17%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
10
83%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

completed650%
unknown217%
recruiting217%
not_yet_recruiting217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12